Bharat Biotech’s Covaxin Gets Emergency Approval


Bharat Biotech’s Covaxin gets emergency approval today. An expert committee of the Central Drugs Standard Control Organization (CDSCO) on Covid-19 on Saturday recommended approval for the limited emergency use of Bharat Biotech’s anti-Corona virus vaccine covaxin in India, which would depend on certain regulatory provisions.

Official sources have given this information. A day earlier on Friday, CDSCO recommended the emergency use of the Corona vaccine ‘Covishield’ of Oxford. Now the Drug Controller General of India (DCGI) will give final approval to both the vaccines.

Currently clinical trials of six Corona vaccines are going on in India. These also include covishield and covaxin. Covishield is the Austroxy vaccine, developed by AstraZeneca and Serum Institute of India, Pune. Kovaxin is an indigenous vaccine developed by Biotech of India in collaboration with the Indian Council of Medical Research.

Disclaimer :- This post is independently published by the author. Infeed neither backs nor assumes liability for the opinions put forth by the author.

Share post:



More like this

Balasore Train Accident : Death Toll Rises to 280

A major train accident took place on Friday near...

BJP Will be Diminished in Coming State Elections : Rahul Gandhi

Congress leader Rahul Gandhi's foreign tour always brings a...

A Global Perspective of Assistive Technology for Differently-Abled People (Divyangjan)

Assistive technology plays a crucial role in empowering individuals...

मीडिया, प्रधानमंत्री, लोकतंत्र, नई संसद और साम्यवाद

एक खबर आती है- "पेंटागन में US के रक्षा...